SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-24-084991
Filing Date
2024-08-01
Accepted
2024-08-01 17:40:41
Documents
2
Period of Report
2024-07-31

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2420669-1_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2420669-1_4seq1.xml 4 3762
2 EXHIBIT 24 tm2420669d1_ex24.htm EX-24 8085
  Complete submission text file 0001104659-24-084991.txt   13532
Mailing Address 910 CLOPPER ROAD SUITE 201S GAITHERSBURG MD 20878
Business Address 910 CLOPPER ROAD SUITE 201S GAITHERSBURG MD 20878 2406541450
Altimmune, Inc. (Issuer) CIK: 0001326190 (see all company filings)

IRS No.: 202726770 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O ALTIMMUNE, INC. 910 CLOPPER ROAD, SUITE 201S GAITHERSBURG MD 20878
Business Address
Harris Matthew Scott (Reporting) CIK: 0001787762 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-32587 | Film No.: 241168128